4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001415889-24-012150
Options or other derivatives
- CHIEF OPERATING OFFICER acquired 208,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Frankenfield Christopher James CHIEF OPERATING OFFICER | 2024-05-01 | Grant or award · Stock Option (right to buy) | +208,000 | 208,000 | D | ||
Loading xslF345X05/form4-05032024_040504.xml…